LIFEVANTAGE CORP Form DFAN14A: Proxy soliciting materials filed by non-management
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-11-02: Form DFAN14A; Description Proxy soliciting materials filed by non-management; Document dfan14a09076057_11012023.htm.
- 2023-10-30: Form DFAN14A; Description Proxy soliciting materials filed by non-management; Document dfan14a09076057_10302023.htm.
- 2023-10-27: Form DFAN14A; Description Proxy soliciting materials filed by non-management; Document dfan14a09076057b_10262023.htm.
- 2023-10-26: Form DFAN14A; Description Proxy soliciting materials filed by non-management; Document dfan14a09076057_10262023.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2023-11-02 | DFAN14A | Proxy soliciting materials filed by non-management | dfan14a09076057_11012023.htm | |
| 2023-10-30 | DFAN14A | Proxy soliciting materials filed by non-management | dfan14a09076057_10302023.htm | |
| 2023-10-27 | DFAN14A | Proxy soliciting materials filed by non-management | dfan14a09076057b_10262023.htm | |
| 2023-10-26 | DFAN14A | Proxy soliciting materials filed by non-management | dfan14a09076057_10262023.htm | |
| 2023-10-25 | DFAN14A | Proxy soliciting materials filed by non-management | dfan14a09076057_10252023.htm | |
| 2023-10-19 | DFAN14A | Proxy soliciting materials filed by non-management | dfan14a09076057_10192023.htm | |
| 2023-10-13 | DFAN14A | Proxy soliciting materials filed by non-management | dfan14a09076057b_10122023.htm | |
| 2023-10-12 | DFAN14A | Proxy soliciting materials filed by non-management | dfan14a09076057_10122023.htm | |
| 2023-09-26 | DFAN14A | Proxy soliciting materials filed by non-management | dfan14a09076057_09252023.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |